| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 14,530 | 12,677 | 10,605 | 16,235 | | Cost of Revenue | 8,365 | 9,345 | 6,833 | 9,593 | | | Gross Profit | 6,165 | 3,332 | 3,772 | 6,642 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,809 | 3,969 | 3,502 | 3,875 | | Non Recurring | 1,379 |
-
|
-
| (580) | | Others | (436) | 872 | 254 | 3,203 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,413 | (1,509) | 16 | 144 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 123 | 163 | 119 | 512 | | Earnings Before Interest And Taxes | 1,233 | (1,346) | 135 | 656 | | Interest Expense | (181) | 92 | 89 | 281 | | Income Before Tax | 1,414 | (1,438) | 46 | 375 | | Income Tax Expense | 388 | (428) | 126 | (46) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,026 | (1,010) | (80) | 421 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,026 | (1,010) | (80) | 421 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,026 | ($1,010) | ($80) | $421 |
|
0.02% Nasdaq 
Income Statement
